pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
IONIS PHARMACEUTICALS INC ($IONS) · news · pharmadog
← back to IONIS PHARMACEUTICALS INC
News mentioning $IONS
88
stories
Aug 7, 26
Intellia finds genetic suspect for liver safety signals with ATTR gene therapy
biospace
Aug 3, 26
5 companies advancing ATTR assets in the wake of Wainua’s fail
biospace
Jul 31, 26
Ionis' top scientist Frank Bennett to retire; Recursion selects its first AI chief
endpoints
Jul 30, 26
Alnylam plunges as earnings deliver ‘one-two punch’
biopharma dive
Jul 30, 26
Chutes & Ladders—Legend CEO departs without successor in place
fiercebiotech
Jul 30, 26
Biogen validated the Alzheimer’s tau theory. CEO Viehbacher still isn’t betting the store
biospace
Jul 29, 26
FDA reviewers criticize Replimune drug; ProMIS climbs on Alzheimer’s data
biopharma dive
Jul 29, 26
Biotechs bring big launches and pharma rivalries into Q2 earnings period
biospace
Jul 27, 26
RA Capital launches rare disease company Oak Hill Bio onto Nasdaq via SPAC
fiercebiotech
Jul 27, 26
AstraZeneca has no plans to ramp up dealmaking in wake of Wainua failure
biospace
Jul 27, 26
STAT+: RA Capital backs upstart rival to Ultragenyx and Ionis in rare brain disease
stat
Jul 23, 26
Roche drops TCE for lupus, but hasn’t given up on autoimmune cell therapies
fiercebiotech
Jul 22, 26
Arrowhead hits ‘best-case scenario’ with latest results for fat-lowering drug
biopharma dive
Jul 22, 26
Arrowhead puts pressure on Ionis with positive data for triglyceride lowering drug
biospace
Jul 14, 26
Biogen data highlight promise, questions surrounding tau-targeting Alzheimer’s drugs
biopharma dive
Jul 9, 26
AstraZeneca, Ionis drug fails big heart disease study in major setback
biopharma dive
Jul 9, 26
STAT+: AstraZeneca, Ionis report major trial failure with heart disease drug
stat
Jul 9, 26
Updated: AstraZeneca sinks on unexpected heart drug trial failure
endpoints
Jun 29, 26
10 clinical trials to watch in the second half of 2026
biopharma dive
Jun 18, 26
Kardigan extends biotech’s streak of big IPOs with $400M haul
biopharma dive
Jun 9, 26
Post-Hoc Live: How much is everyone in biopharma getting paid?
endpoints
May 28, 26
GSK, Ionis unveil data for hepatitis B drug touted as ‘functional cure’
biopharma dive
May 28, 26
GSK spells out positive Phase 3 data for hepatitis B drug it licensed from Ionis
endpoints
May 14, 26
Biogen pushing tau drug forward despite Alzheimer’s study failure
biopharma dive
May 11, 26
GSK cuts deal with Sino to broaden reach of hepatitis B drug
biopharma dive
Apr 29, 26
Chiesi to buy KalVista in $1.9B deal for rare disease drug
biopharma dive
Apr 29, 26
FDA tests out ‘real-time’ clinical trials; AbbVie closes in on a KRAS biotech
biopharma dive
Apr 28, 26
Pfizer deals extend patent life for a top-selling rare disease drug
biopharma dive
← prev
page 3 of 3
next →